Approval · Notice of Compliance 3133 · 1998
MIRAPEX: Notice of Compliance 3133
Issued January 29, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3133
- Date
- January 29, 1998
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antiparkinsonian agent/dopamine agonist
Products in this notice
Medicinal ingredients
- PRAMIPEXOLE DIHYDROCHLORIDE 0.25 MG per TAB
- PRAMIPEXOLE DIHYDROCHLORIDE 1 MG per TAB
- PRAMIPEXOLE DIHYDROCHLORIDE 1.5 MG per TAB